CCGHE at CROI 2020
MONDAY, MARCH 9
An mHealth CHW intervention trials in an HIV hyperendemic community in Rakai, Uganda
Chang LW, Mbabali I, Kong X, Amico R, Kennedy CE, Nalugoda F, Anok A, Serwadda D, Ssekasanvu J, Quinn TC, Reynolds SJ, Gray RH, Wawer M, Hutton H, Nakigozi G
Oral Abstract 44 | Oral Abstract Session O-04: Community- and Clinic-Based HIV Treatment, Prevention Interventions, and Insights
10:30 AM | Ballroom B
Factors associated with gestational diabetes in HIV+ and HIV- women in Pune, India
Chebrolu P, Alexander M, Bhosale R, Naik S, Patil N, Gupta A, Mathad J
Poster 774 | Poster Session P-O02: Session: Chronic Diseases in Maternal Health: Persistent Problems for Pregnant or Postpartum Women
2:30–4:00 PM | Poster Hall B
Geographic and individual risk factors for TB or death in the BRIEF-TB trial (A5279)
Riviere C, Juste MAJ, Ramchandani R, Gupta A, Benson CA, Masheto G, Supparatpinyo K, Mohapi L, da Silva Escada RO, Mngqibisa R, Kanyama C, Langat D, Swindells S, Chaisson RE, for the A5279/BRIEF TB Study Team
Poster 726 | Poster Session: P-N02 Latent TB Infection: Risk Factors, Treatment, and Prevention
2:30–4:00 PM | Poster Hall B
Adjusted analysis of effect of IPT on adverse pregnancy outcomes in women with HIV
Theron G, Chakhtoura N, Montepiedra G, Aaron L, Jean-Phillipe P, Weinberg A, McCarthy K, Nematadzira T, Masheto G, Chipato T, Onyango-Makumbi C, Gupta A, the IMPAACT P1078 Team
Poster 727 | Poster Session: P-No2 Latent TB Infection: Risk Factors, Treatment, and Prevention
2:30–4:00 PM | Poster Hall B
Population-level HIV viral load varies by gender, age, and location in Rakai, Uganda
Kyle I, Kagaagi J, Kigozi G, Nakigozi G, Ssekbugu R, Nalugoda F, Grabowski MK, Chang LW, Wawer M, Serwadda D, Gray RH, Quinn T, Reynolds SJ, Rattman O for the Rakai Health Sciences Program
Poster 865 | Poster Session: P-Q03 Viral Load and Outcomes
2:30–4:00 PM | Poster Hall D
Waxing and waning HIV risk: Dynamics of PrEP eligibility in Rakai, Uganda
Ssempijja V, Ssekubugu R, Kigozi G, Kakigozi G, Kagaayi J, Lutalo T, Ndyanabo A, Ekstrom AM, Serwadda D, Quinn TC, Gray RH, Wawer M, Chang LW, Reynolds SJ
Poster 982 | Poster Session P-S02: PrEP Eligibility and Modes of Delivery
2:30–4:00 PM | Poster Hall D
TUESDAY, MARCH 10
Early bactericidal activity of meropenem (+ Amox/Clav) with and without rifampin for TB
De Jager V, Abufathi AA, Feyt H, Gupte N, Vanker N, Barnes G, van Brakel E, Nuermberger E, Dorman SE, Svensson EM, Diacon AH, Dooley KE, for the COMRADE Study Team
Poster 732 | Poster Session P-N03: Early Bactericidal Activity, PK/PD, and Drug Interactions in TB Treatment
2:30–4:00 PM | Poster Hall B
Effect of rifamycins on pretomanid exposure in patients with pulmonary TB
Abdelwahab MT, Ignatius E, Denti P, Dooley KE, Gupte N , Dawson R, Barnes G, Narunsky K, Hendricks B
Poster 733 | Poster Session P-N03: Early Bactericidal Activity, PK/PD, and Drug Interactions in TB Treatment
2:30–4:00 PM | Poster Hall B
Indeterminate HIV rapid-test results: Outcomes and risk factors
Mwinnyaa G, Grabkowski MK, Gray RH, Wawer M, Chang LW, Ssekasanvu J, Kagaayi J, Kigozi G, Galiwango RM, Ndyanabo A, Serwadda D, Quinn TC, Reynolds SJ, Laeyendecker O, for the Rakai Community Cohort Study
Poster 950 | Poster Session P-R03: Point-of-Care Testing
2:30–4:00 PM | Poster Hall D
Long-term effectiveness of voluntary medical male circumcision for HIV prevention
Loevinsohn G, Kigozi G, Kagaayi J, Nalugoda F, Chang LW, Serwadda D, Reynolds SJ, Nakigozi G, Ssekubugu R, Wawer M, Tobian A, Gray RH, Grabowski MK, for the Rakai Sciences Program
Poster 1037 | Poster Session PS12: Male Circumcision and the Penile Microbiome
2:30–4:00 PM | Poster Hall D
“Stylish Man” cluster RCT to increase mal circumcision for adult men ≥ 19, Uganda
Wawer M, Kigozi G, Mugamba S, Zikusooka A, Kagaayi J, Serwadda D, Ndyanabo A, Ssekubugu R, Sseasanvu J, Chang LW, Gray RH
Poster 1037 | Poster Session PS12: Male Circumcision and the Penile Microbiome
2:30–4:00 PM | Poster Hall D
Randomized trial of HIV-ASSIST versus guidelines for ART selection by trainees
Ramirez J, Maddali M, Nematollahi S, Li JZ, Shah M
Poster 1119 | Poster Session P-U09: Antiretroviral Therapy Delivery
2:30–4:00 PM | Poster Hall D
WEDNESDAY, MARCH 11
Predictors of tuberculosis infection in MDR-TB household contacts ≥15 years old
Kim S, Gupta A, Wu X, Hughes M, Dawson R, Mave V, Kumarasamy, Smith B, Rustomgee R, Shah NS, Hesseling A, Swindells S, Churchyard G, for the ACTG/IMPAACT A5300/I2003 PHOENIx Feasibility Study Team
Oral Abstract 139 | Oral Abstract Session O-12: Tuberculosis, Opportunistic Infections, and HIV Testing
10:30 AM | Ballroom C
Rifapentine pharmacokinetics and safety in pregnant women with and without HIV on 3HP
Mathad JS, Savic RM, Britto P, Wiesner L, Townley E, Chakhtoura N, Bradford S, Patil S, Vhembo T, Lespinasse D, Langat D, Werarak P, Kamthunzi P, Gupta A, Dooley KE
Oral Abstract 144 LB | Oral Abstract Session O-12: Tuberculosis, Opportunistic Infections, and HIV Testing
11:45 AM | Ballroom C
Rapidly declining HIV incidence among men and women in Rakai, Uganda
Nakigozi G, Chang LW, Reynolds SJ, Nalugoda F, Kigozi G, Quinn TC, Gray RH, Kisakye A, Ndyanabo A, Ssekubugu R, Serwadda D, Wawer M, Kayaayi J, Grabowski MK, for the Rakai Health Sciences Program
Oral Abstract 150 | Oral Abstract Session O-13: The Good, the Bad, and the Ugly: HIV Incidence and Outcomes in Selected Populations
11:15 AM | Ballroom B
Association of hypertension and ART use in a population-based cohort, Rakai, Uganda
Mongo-Bua G, SSempijja V, Ndyanabo A, Nabukalu D, Basiima J, Kankaka E, Nalugoda F, Nakigozi G, Kagaayi J, Chang LW, Gray RH, Wawer M, Kigozi G, Reynolds SJ
Poster 660 | Poster Session P-L05: Clinical and Subclinical Cardiovascular Outcomes in HIV
2:30–4:00 PM | Poster Hall B
Trends in linkage into care after “Test and Start” among adolescents and young adults
Kigozi DS, Kreniske P, Chen I, Nalugoda F, Hoffman S, Kigozi G, Nakigozi G, Ssekubugu R, Kankaka E, Gray RH, Wawer M, Chang LW, Reynolds SJ, Lualo T, Kagaayi J
Poster 1123 | Poster Session P-U09: Linkage to Care
2:30–4:00 PM | Poster Hall D